Patent · US Active

Oral dosage form

US11033589B2 · kind B2 · utility

0Cited by

8References

5Claims

0Family size

Assignee

SYMRISE AG · DE

Inventors

Rolf Daniels · Salzgitter, DE
Anja Hoffmann · Neuffen, DE
Marcus Rudolf Götz · Bodenfelde, DE
Jörg Thilo Fischer · Brakel, DE
Kerstin Holmgren · Helsingborg, SE

Key dates

Filing date	Sep 18, 2019
Grant date	Jun 15, 2021
Priority date	—
Expiry date	Sep 18, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2035/115
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is in the field of delivering an active substance to the oral cavity and relates to mucoadhesive active composition and corresponding mucoadhesive dosage form, which can deliver an active substance within the oral cavity, especially an orodispersible tablet for delivering probiotic substance. The present invention also relates to a method of producing the said composition and a method of processing the composition into a mucoadhesive dosage form, especially an orodispersible tablet. The present invention moreover relates to a system and a method for testing the mucoadhesion of a dosage form.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.